News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
628,210 Results
Type
Article (44837)
Company Profile (342)
Press Release (583014)
Multimedia
Podcasts (129)
Webinars (21)
Section
Business (168297)
Career Advice (2477)
Deals (30515)
Drug Delivery (130)
Drug Development (79297)
Employer Resources (149)
FDA (14788)
Job Trends (13120)
News (297741)
Policy (28758)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2715)
Academic (1)
Accelerated approval (45)
Adcomms (34)
Allergies (173)
Alliances (43082)
ALS (213)
Alzheimer's disease (1856)
Antibody-drug conjugate (ADC) (467)
Approvals (15102)
Artificial intelligence (659)
Autoimmune disease (281)
Automation (46)
Bankruptcy (328)
Best Places to Work (10700)
BIOSECURE Act (17)
Biosimilars (207)
Biotechnology (257)
Bladder cancer (190)
Brain cancer (72)
Breast cancer (751)
Cancer (5814)
Cardiovascular disease (481)
Career advice (2110)
Career pathing (44)
CAR-T (334)
CDC (58)
Celiac Disease (1)
Cell therapy (906)
Cervical cancer (41)
Clinical research (68647)
Collaboration (2033)
Company closure (6)
Compensation (1011)
Complete response letters (91)
COVID-19 (2716)
CRISPR (117)
C-suite (1147)
Cystic fibrosis (155)
Data (7710)
Decentralized trials (3)
Denatured (30)
Depression (174)
Dermatology (82)
Diabetes (575)
Diagnostics (6347)
Digital health (45)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (329)
Drug pricing (198)
Drug shortages (26)
Duchenne muscular dystrophy (297)
Earnings (66477)
Editorial (67)
Employer branding (21)
Employer resources (141)
Events (96130)
Executive appointments (1113)
FDA (18351)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1666)
Gene editing (250)
Generative AI (60)
Gene therapy (757)
GLP-1 (1095)
Government (4578)
Grass and pollen (7)
Guidances (404)
Healthcare (17398)
HIV (80)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (321)
Immuno-oncology (93)
Indications (176)
Infectious disease (3052)
Inflammatory bowel disease (231)
Inflation Reduction Act (16)
Influenza (133)
Intellectual property (289)
Interviews (532)
IPO (14397)
IRA (53)
Job creations (2752)
Job search strategy (1693)
JPM (66)
Kidney cancer (21)
Labor market (74)
Layoffs (563)
Leadership (45)
Legal (6102)
Liver cancer (101)
Longevity (29)
Lung cancer (778)
Lymphoma (418)
Machine learning (58)
Management (52)
Manufacturing (942)
MASH (201)
Medical device (11575)
Medtech (11663)
Mergers & acquisitions (17290)
Metabolic disorders (1526)
mRNA (215)
Multiple sclerosis (184)
NASH (24)
Neurodegenerative disease (430)
Neuropsychiatric disorders (118)
Neuroscience (3407)
Neurotech (1)
NextGen: Class of 2026 (5996)
Non-profit (4167)
Now hiring (71)
Obesity (718)
Opinion (317)
Ovarian cancer (218)
Pain (254)
Pancreatic cancer (295)
Parkinson's disease (369)
Partnered (32)
Patents (581)
Patient recruitment (666)
Peanut (63)
People (56351)
Pharmaceutical (50)
Pharmacy benefit managers (23)
Phase 1 (21566)
Phase 2 (30328)
Phase 3 (22544)
Pipeline (8178)
Policy (318)
Postmarket research (2396)
Preclinical (9151)
Press Release (60)
Prostate cancer (296)
Psychedelics (64)
Radiopharmaceuticals (333)
Rare diseases (1115)
Real estate (4541)
Recruiting (64)
Regulatory (23343)
Reports (33)
Research institute (2360)
Resumes & cover letters (364)
Rett syndrome (37)
RNA editing (26)
RSV (83)
Schizophrenia (187)
Series A (286)
Series B (212)
Service/supplier (3)
Sickle cell disease (116)
Special edition (25)
Spinal muscular atrophy (173)
Sponsored (43)
Startups (3238)
State (2)
Stomach cancer (19)
Supply chain (111)
Tariffs (78)
The Weekly (97)
Vaccines (1069)
Venture capital (113)
Weight loss (478)
Women's health (103)
Worklife (20)
Date
Today (2)
Last 7 days (898)
Last 30 days (2997)
Last 365 days (28913)
2026 (10994)
2025 (29038)
2024 (33512)
2023 (37467)
2022 (48408)
2021 (52015)
2020 (49975)
2019 (42538)
2018 (32079)
2017 (29603)
2016 (28149)
2015 (32899)
2014 (25341)
2013 (20525)
2012 (21738)
2011 (22667)
2010 (20372)
Location
Africa (761)
Alabama (90)
Alaska (4)
Arizona (272)
Arkansas (15)
Asia (38202)
Australia (7545)
California (12032)
Canada (3583)
China (1325)
Colorado (508)
Connecticut (497)
Delaware (392)
Europe (86231)
Florida (1827)
Georgia (372)
Hawaii (3)
Idaho (60)
Illinois (941)
India (85)
Indiana (528)
Iowa (19)
Japan (512)
Kansas (122)
Kentucky (43)
Louisiana (40)
Maine (63)
Maryland (1483)
Massachusetts (8731)
Michigan (324)
Minnesota (632)
Mississippi (6)
Missouri (139)
Montana (29)
Nebraska (25)
Nevada (128)
New Hampshire (83)
New Jersey (3305)
New Mexico (27)
New York (3166)
North Carolina (1553)
North Dakota (7)
Northern California (5906)
Ohio (341)
Oklahoma (20)
Oregon (38)
Pennsylvania (2382)
Puerto Rico (25)
Rhode Island (44)
South America (1031)
South Carolina (79)
South Dakota (2)
Southern California (4855)
Tennessee (184)
Texas (1952)
United States (42723)
Utah (361)
Vermont (1)
Virginia (282)
Washington D.C. (71)
Washington State (996)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
628,210 Results for "tarveda therapeutics fomerly known as blend therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
PARTNERED
Staying Agile: Blended Workforces Offer Strategic Approach to Business Needs
Building and scaling biopharma workforces can go beyond recruiting permanent employees to include fractional workers and consultants. A Slone Partners executive discusses how these blended workforces operate, highlighting the strategic benefits.
September 22, 2025
·
4 min read
·
BioSpace Insights
Press Releases
VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026
May 7, 2026
·
3 min read
Press Releases
Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
May 7, 2026
·
7 min read
Earnings
Sarepta, Amylyx and Neumora look ahead to key catalysts as Q1 earnings roll in
As Q1 earnings arrive, three biotechs have big quarters ahead, with two—Amylyx and Neumora Therapeutics—betting at least partly on novel assets for obesity.
May 5, 2026
·
5 min read
·
Heather McKenzie
Press Releases
Asha Therapeutics Launches as First Atom Therapeutics, a Zero-Shot De Novo Drug Design Company
March 30, 2026
·
2 min read
Press Releases
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
May 4, 2026
·
8 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
April 21, 2026
·
4 min read
Press Releases
Assertio Announces Agreement to be Acquired by Garda Therapeutics
April 8, 2026
·
9 min read
Press Releases
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
March 26, 2026
·
2 min read
1 of 62,821
Next
